Correlation Between Uniqure NV and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Uniqure NV and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uniqure NV and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Uniqure NV and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Uniqure NV and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uniqure NV with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uniqure NV and Syndax Pharmaceuticals.
Diversification Opportunities for Uniqure NV and Syndax Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Uniqure and Syndax is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Uniqure NV and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Uniqure NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uniqure NV are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Uniqure NV i.e., Uniqure NV and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Uniqure NV and Syndax Pharmaceuticals
Given the investment horizon of 90 days Uniqure NV is expected to under-perform the Syndax Pharmaceuticals. In addition to that, Uniqure NV is 2.13 times more volatile than Syndax Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 2,132 in Syndax Pharmaceuticals on August 31, 2024 and sell it today you would lose (460.00) from holding Syndax Pharmaceuticals or give up 21.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Uniqure NV vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Uniqure NV |
| Syndax Pharmaceuticals |
Uniqure NV and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Uniqure NV and Syndax Pharmaceuticals
The main advantage of trading using opposite Uniqure NV and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uniqure NV position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Uniqure NV vs. Rocket Pharmaceuticals | Uniqure NV vs. Rhythm Pharmaceuticals | Uniqure NV vs. Solid Biosciences LLC | Uniqure NV vs. MeiraGTx Holdings PLC |
| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |